PubRank

Kenneth McIntosh

Author PubWeight™ 66.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004 6.48
2 Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA 2006 5.84
3 Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis 2008 3.09
4 HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response. J Immunol 2005 2.24
5 Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trials to clinical practice. JAMA 2005 1.91
6 A behavioral and cognitive profile of clinically stable HIV-infected children. Pediatrics 2006 1.78
7 Early immunological predictors of neurodevelopmental outcomes in HIV-infected children. Clin Infect Dis 2009 1.68
8 Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine. Clin Infect Dis 2010 1.64
9 Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study. J Infect Dis 2006 1.64
10 Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting. Clin Infect Dis 2008 1.60
11 Quality of life for children and adolescents: impact of HIV infection and antiretroviral treatment. Pediatrics 2006 1.42
12 Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children. Pediatrics 2005 1.39
13 Human bocavirus: developing evidence for pathogenicity. J Infect Dis 2006 1.28
14 Growth in human immunodeficiency virus-infected children receiving ritonavir-containing antiretroviral therapy. Arch Pediatr Adolesc Med 2002 1.25
15 History and recent advances in coronavirus discovery. Pediatr Infect Dis J 2005 1.24
16 Coronaviruses in the limelight. J Infect Dis 2005 1.20
17 Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand. PLoS Med 2013 1.20
18 Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapy. J Allergy Clin Immunol 2005 1.18
19 Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand. J Infect Dis 2007 1.07
20 Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women. Pediatrics 2009 1.06
21 Increased incidence of asthma in HIV-infected children treated with highly active antiretroviral therapy in the National Institutes of Health Women and Infants Transmission Study. J Allergy Clin Immunol 2008 1.05
22 Maternal HIV-1 DNA load and mother-to-child transmission. AIDS Patient Care STDS 2007 1.05
23 A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand. Pediatr Infect Dis J 2010 1.05
24 Immune reconstitution after receipt of highly active antiretroviral therapy in children with advanced or progressive HIV disease and complete or partial viral load response. J Infect Dis 2005 1.02
25 Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children. Antivir Ther 2011 1.02
26 Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: a bayesian analysis. PLoS One 2011 0.96
27 HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana. AIDS 2013 0.94
28 The first influenza pandemic of the 21st century. Ann Saudi Med 2010 0.94
29 The interrelated transmission of HIV-1 and cytomegalovirus during gestation and delivery in the offspring of HIV-infected mothers. J Acquir Immune Defic Syndr 2011 0.93
30 Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission. Pediatr Infect Dis J 2006 0.92
31 Middle East Respiratory Syndrome Coronavirus (MERS-CoV): a perpetual challenge. Ann Saudi Med 2013 0.88
32 The Pediatric AIDS Severity Score (PASS): a multidimensional AIDS-severity adjustment for pediatric HIV infection. J Acquir Immune Defic Syndr 2006 0.86
33 Reconstitution of virus-specific CD4 proliferative responses in pediatric HIV-1 infection. J Immunol 2003 0.85
34 Simple Pediatric AIDS Severity Score (PASS): a pediatric severity score for resource-limited settings. J Acquir Immune Defic Syndr 2006 0.84
35 Human immunodeficiency virus-hepatitis C virus co-infection in pregnant women and perinatal transmission to infants in Thailand. Int J Infect Dis 2010 0.83
36 Haematological safety of perinatal zidovudine in pregnant HIV-1-infected women in Thailand: secondary analysis of a randomized trial. PLoS Clin Trials 2007 0.83
37 Pharmacokinetic characteristics of ritonavir, zidovudine, lamivudine, and stavudine in children with human immunodeficiency virus infection. Pharmacotherapy 2004 0.82
38 Hematological safety of perinatal exposure to zidovudine in uninfected infants born to HIV type 1-infected women in Thailand. AIDS Res Hum Retroviruses 2010 0.80
39 The SARS coronavirus: rapid diagnostics in the limelight. Clin Chem 2003 0.79
40 Association of HIV-1 viral phenotype in the MT-2 assay with perinatal HIV transmission. J Acquir Immune Defic Syndr 2002 0.79
41 A new virulent human coronavirus: how much does tissue culture tropism tell us? J Infect Dis 2013 0.78
42 Evaluation of coxsackievirus infection in children with human immunodeficiency virus type 1-associated cardiomyopathy. J Infect Dis 2002 0.77
43 Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced children with human immunodeficiency virus infection. Pediatr Infect Dis J 2002 0.77
44 Switch from ritonavir to indinavir in combination therapy for HIV-1-infected children. Clin Infect Dis 2005 0.76
45 Absence of detectable viremia in a perinatally HIV-1-infected teenager after discontinuation of antiretroviral therapy. J Allergy Clin Immunol 2006 0.76
46 Prevention of HIV-1 transmission with postexposure prophylaxis after inadvertent infected blood transfusion. AIDS 2014 0.75
47 Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV. PLoS One 2015 0.75
48 Development of dual-class antiretroviral drug resistance in a child coinfected with HIV and tuberculosis: a case report from KwaZulu-Natal, South Africa. J Trop Pediatr 2008 0.75
49 Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV. PLoS One 2015 0.75
50 Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338). AIDS Res Ther 2007 0.75
51 Antimicrobial Prophylaxis in Children with HIV Infection. Clin Infect Dis 2004 0.75
52 Cotrimoxazole prophylaxis and risk of severe anemia or severe neutropenia in HAART-exposed, HIV-uninfected infants. PLoS One 2013 0.75